CNMD - CONMED Corporation
NEXT EARNINGS:
Apr 29, 2026
EPS Est: $0.82
|
Rev Est: $310.6M
Price:
--
--
|
CONSENSUS:
Hold
DETAILS
|
PRICE TARGET:
$78.00
DETAILS
HIGH:
$95.00
LOW:
$61.00
MEDIAN:
$78.00
CONSENSUS:
$78.00
UPSIDE:
69.34%
Market Cap:
1.43B
Volume:
550,153
Avg Volume:
619,960
52 Week Range:
35.37-64.87
Sector:
Healthcare
Industry:
Medical - Devices
Beta:
0.96
Last Dividend:
$0.60
Exchange:
NYSE
Country:
US
Employees:
3,900
IPO Date:
1987-07-23
EPS (TTM):
1.52
P/E Ratio:
26.78
Revenue (TTM):
1.37B
Total Assets:
2.33B
Total Debt:
834.94M
Cash & Equiv:
40.82M
Rev Growth (5Y):
9.8%
EPS Growth (5Y):
35.7%
FCF Growth (5Y):
24.0%
ROCE:
5.1%
Debt/Equity:
0.81
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2026-01-28 | $1.43 | $1.32 | +8.3% | $373.2M | $310.8M | +20.1% |
| 2025-11-05 | $1.08 | $1.05 | +2.9% | $337.9M | $366.9M | -7.9% |
| 2025-07-30 | $1.15 | $1.13 | +1.8% | $342.3M | $334.6M | +2.3% |
| 2025-04-30 | $0.95 | $0.81 | +17.3% | $321.3M | $313.4M | +2.5% |
| 2025-02-05 | $1.34 | $1.20 | +11.7% | $347.9M | $341.0M | +2.0% |
| 2024-10-30 | $1.05 | $0.99 | +6.1% | $316.7M | $318.1M | -0.4% |
| 2024-07-31 | $0.98 | $0.91 | +7.7% | $330.7M | $332.3M | -0.5% |
| 2024-04-24 | $0.79 | $0.74 | +6.8% | $311.6M | $306.8M | +1.6% |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.37B | 1.31B | 1.24B | 1.05B | 1.01B | 862.46M | 955.10M | 859.63M | 796.39M | 763.52M | 719.17M | 734.47M |
| Net Income | 47.05M | 132.42M | 64.46M | (80.58M) | 62.54M | 9.52M | 28.62M | 40.85M | 55.49M | 14.66M | 30.50M | 32.19M |
| EPS | 1.52 | 4.29 | 2.10 | -2.68 | 2.14 | 0.33 | 1.01 | 1.45 | 1.99 | 0.53 | 1.10 | 1.17 |
| Total Assets | 2.33B | 2.31B | 2.30B | 2.30B | 1.77B | 1.75B | 1.78B | 1.37B | 1.36B | 1.33B | 1.11B | 1.10B |
| Total Debt | 834.94M | 905.78M | 991.25M | 1.05B | 684.66M | 776.45M | 793.17M | 456.90M | 486.44M | 488.29M | 269.47M | 241.44M |
| Cash & Equivalents | 40.82M | 24.46M | 24.30M | 28.94M | 20.85M | 27.36M | 25.86M | 17.51M | 32.62M | 27.43M | 72.50M | 66.33M |
| Operating Cash Flow | 170.69M | 166.97M | 125.35M | 33.37M | 111.77M | 64.53M | 95.13M | 74.70M | 65.57M | 38.22M | 48.07M | 65.18M |
| Free Cash Flow | 150.88M | 153.88M | 106.32M | 11.58M | 96.90M | 51.52M | 75.07M | 58.19M | 52.72M | 23.47M | 33.06M | 49.77M |
| FCF per Share | 4.86 | 4.99 | 3.47 | 0.39 | 3.32 | 1.80 | 2.65 | 2.07 | 1.89 | 0.84 | 1.20 | 1.82 |
| Book Value | 1.03B | 962.68M | 834.22M | 745.54M | 785.43M | 709.04M | 710.47M | 662.27M | 631.43M | 580.58M | 585.07M | 581.30M |
| Cash & ST Investments | 40.82M | 24.46M | 24.30M | 28.94M | 20.85M | 27.36M | 25.86M | 17.51M | 32.62M | 27.43M | 72.50M | 66.33M |
| ROC Equity | 0.05 | 0.14 | 0.08 | -0.11 | 0.08 | 0.01 | 0.04 | 0.06 | 0.09 | 0.03 | 0.05 | 0.06 |